Literature DB >> 19278839

Long-term exposure to magnetic fields and the risks of Alzheimer's disease and breast cancer: Further biological research.

Zoreh Davanipour1, Eugene Sobel.   

Abstract

OBJECTIVE: Extremely low frequency (ELF) and radio frequency (RF) magnetic fields (MFs) pervade our environment. Whether or not these magnetic fields are associated with increased risk of serious diseases, e.g., cancers and Alzheimer's disease, is thus important when developing a rational public policy. The Bioinitiative Report was an effort by internationally recognized scientists who have spent significant time investigating the biological consequences of exposures to these magnetic fields to address this question. Our objective was to provide an unbiased review of the current knowledge and to provide our general and specific conclusions.
RESULTS: The evidence indicates that long-term significant occupational exposure to ELF MF may certainly increase the risk of both Alzheimer's disease and breast cancer. There is now evidence that two relevant biological processes (increased production of amyloid beta and decreased production of melatonin) are influenced by high long-term ELF MF exposure that may lead to Alzheimer's disease. There is further evidence that one of these biological processes (decreased melatonin production) may also lead to breast cancer. Finally, there is evidence that exposures to RF MF and ELF MF have similar biological consequences.
CONCLUSION: It is important to mitigate ELF and RF MF exposures through equipment design changes and environmental placement of electrical equipment, e.g., AC/DC transformers. Further research related to these proposed and other biological processes is required.

Entities:  

Year:  2009        PMID: 19278839     DOI: 10.1016/j.pathophys.2009.01.005

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  8 in total

1.  Generation and propagation of yeast prion [URE3] are elevated under electromagnetic field.

Authors:  Hui-Yong Lian; Kang-Wei Lin; Chuanjun Yang; Peng Cai
Journal:  Cell Stress Chaperones       Date:  2017-12-06       Impact factor: 3.667

2.  Retinoic acid inhibits the cytoproliferative response to weak 50‑Hz magnetic fields in neuroblastoma cells.

Authors:  María Ángeles Trillo; María Antonia Martínez; María Antonia Cid; Alejandro Úbeda
Journal:  Oncol Rep       Date:  2012-12-24       Impact factor: 3.906

Review 3.  Magnetic field effects in biology from the perspective of the radical pair mechanism.

Authors:  Hadi Zadeh-Haghighi; Christoph Simon
Journal:  J R Soc Interface       Date:  2022-08-03       Impact factor: 4.293

Review 4.  The effects of extremely low-frequency magnetic fields on melatonin and cortisol, two marker rhythms of the circadian system.

Authors:  Yvan Touitou; Brahim Selmaoui
Journal:  Dialogues Clin Neurosci       Date:  2012-12       Impact factor: 5.986

5.  Deficits in water maze performance and oxidative stress in the hippocampus and striatum induced by extremely low frequency magnetic field exposure.

Authors:  Yonghua Cui; Zhiqiang Ge; Joshua Dominic Rizak; Chao Zhai; Zhu Zhou; Songjie Gong; Yi Che
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

6.  Early exposure to intermediate-frequency magnetic fields alters brain biomarkers without histopathological changes in adult mice.

Authors:  Tin-Tin Win-Shwe; Shin Ohtani; Akira Ushiyama; Naoki Kunugita
Journal:  Int J Environ Res Public Health       Date:  2015-04-22       Impact factor: 3.390

7.  Low frequency magnetic fields enhance antitumor immune response against mouse H22 hepatocellular carcinoma.

Authors:  Yunzhong Nie; Yueqiu Chen; Yongbin Mou; Leihua Weng; Zhenjun Xu; Youwei Du; Wenmei Wang; Yayi Hou; Tingting Wang
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

Review 8.  Yeast Models for Amyloids and Prions: Environmental Modulation and Drug Discovery.

Authors:  Tatiana A Chernova; Yury O Chernoff; Keith D Wilkinson
Journal:  Molecules       Date:  2019-09-18       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.